2025 Scottsdale Headache Symposium Pre-Course 8: Real-World Pharmacologic Management in Headache Disorders: Navigating Clinical Grey Zones

Course Instructions

  1. AHS members have complimentary access to the recorded content within this course. All others should create a new visitor account or login as a visitor to purchase the course.
  2. Once logged in or purchased, click "Take course" to access recorded content, complete the meeting evaluation, claim CME, and download a certificate.

Target Audience

Since the inaugural meeting in 1970, the Scottsdale Headache Symposium® continues to be a successful venue for providing practical, clinical, evidence-based information on the diagnosis, management and treatment of headache patients.

Learning Objectives

At the conclusion of the program, participants will report their intention to:

  1. Understand the management strategies for nausea and vomiting as a debilitating symptom of migraine, improving patient care and outcome, and list the pharmacologic and non-pharmacologic treatments as well as their side effects and contraindications.
  2. Apply clinical reasoning to navigate complex pharmacologic decisions in preventive migraine treatment.
Course summary
Available credit: 
  • 3.00 AMA PRA Category 1 Credit™
  • 3.00 Participation
Course opens: 
01/12/2026
Course expires: 
01/12/2027
Cost:
$500.00

Disclosure Information

The planners and faculty for this activity did not have any relationships to disclose unless listed below. All relevant relationships were mitigated prior to the start of the activity according to ACCME Standards.

PURPOSE/OBJECTIVE

This educational activity is designed to educate participants on how to understand the management strategies for nausea and vomiting as a debilitating symptom of migraine, improve patient care and outcome, list the pharmacologic and non-pharmacologic treatments as well as their side effects and contraindications, and apply clinical reasoning to navigate complex pharmacologic decisions in preventive migraine treatment.

ACCREDITATION STATEMENT

The American Headache Society® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

The American Headache Society® designates this enduring material for a maximum of 3.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

INSTRUCTIONS FOR CLAIMING CME:

  • Login/create a new visitor account (when creating an account, please be sure to use the email address you used during registration for the Annual Meeting).
  • Watch the session recording.
  • Complete the post-activity evaluation. 
  • Enter the number of CME credits being claimed*.
  • Download your certificate.

*Please note: The maximum number of credits is calculated based on watching the entire session recording.

FINANCIAL DISCLOSURES

The planners and faculty for this activity did not have any relationships to disclose unless listed here. All relevant relationships were mitigated prior to the start of the activity according to ACCME Standards.

DISCLOSURE OF COMMERCIAL SUPPORT

The American Headache Society® received support for the SHS2025 meeting from the following organizations:

AbbVie Inc.
Axsome Therapeutics
Lundbeck LLC.
Pfizer Inc.

BIBLIOGRAPHY

References are available within the session recording.

Available Credit

  • 3.00 AMA PRA Category 1 Credit™
  • 3.00 Participation

Price

Cost:
$500.00
Please login or register to take this course.